Mass spectrometry–based proteomics, bioinformatics, biochemical and cell-culture services for biopharmaceutical drug discovery and clinical research. Capabilities include unbiased drug-target identification, drug selectivity and target-engagement profiling, mode-of-action analysis, pharmacodynamics and biomarker characterization.